Methylene Blue for Treatment of Hospitalized COVID-19 Patients, Randomized, Controlled, Open-Label Clinical Trial, Phase 3

Hamidi Alamdari, D, Hafizi Lotfabadi, S, Mavaji Darban, B, Agheli-Rad, M, Saadatian, S, Hashemi, S H, Barazandeh Ahmadabadi, F, Morovatdar, N, Arastoo, M & Bhushan, B 2021, 'Methylene Blue for Treatment of Hospitalized COVID-19 Patients, Randomized, Controlled, Open-Label Clinical Trial, Phase 3', Aristotle Biomedical Journal, vol. 3, no. 2, pp. 12-18. < https://ejournals.lib.auth.gr/ABJ/article/view/8158/7922 >